Grove Collaborative (GROV) Q1 2026 earnings review
Profitability Reversing Upward, But Top-Line Remains in a Trough
Grove Collaborative delivered its second consecutive quarter of positive Adjusted EBITDA ($0.3M) despite a punishing 16.8% YoY drop in net revenue. The company is actively choosing profitability over growth, letting its leaner cost structure flow to the bottom line while intentionally suppressing advertising spend. Management insists 26Q1 is the revenue trough and raised full-year guidance, but with active customers down 18.5% YoY, the company must now prove it can successfully re-accelerate customer acquisition without breaking its fragile profit margins.
🐂 Bull Case
Grove has proven it can operate profitably on a much smaller revenue base, marking its second straight quarter of positive Adjusted EBITDA and raising full-year guidance to breakeven-to-positive.
The disastrous 2025 eCommerce migration is reportedly behind them. The company successfully launched a rebuilt, internally controlled mobile app that handles half of non-autoship orders.
🐻 Bear Case
Active customers dropped to 553,000, down 18.5% YoY and down roughly 46,000 sequentially from Q4. The business continues to shrink significantly.
With only $10.4M in total cash and equivalents, Grove has virtually zero margin for error as it attempts to re-accelerate marketing spend in the coming quarters.
⚖️ Verdict: ⚪
Neutral. Management deserves credit for stopping the bleeding and delivering positive EBITDA. However, the top-line destruction is severe, and it remains unproven whether they can efficiently acquire new customers with a highly constrained balance sheet.
Key Themes
In-House Mobile App Rebuild
After a disastrous third-party platform migration in early 2025, Grove took technology back into its own hands. The launch of a redesigned, internally controlled mobile application in Q1 is a critical technical innovation. With approximately half of non-autoship orders originating on mobile, this 5-star app acts as a primary driver for user retention, order frequency, and personalized shopping experiences.
Structural SG&A and Fulfillment Reductions
Operating expenses fell 21.9% YoY to $20.8M. This is a direct driver of the reversing margin profile, reflecting the full-quarter benefit of a November 2025 reduction in force and lower fulfillment costs due to reduced order volume. The company is extracting more margin from fewer orders.
Grove Green Rewards Restructuring Promos
Gross margin expanded 180 basis points YoY to 54.8%. This accelerating profitability metric was driven by a shift away from broad, margin-crushing discounting toward the targeted 'Grove Green Rewards' loyalty program launched in late 2025. It is successfully driving higher DTC net revenue per order ($67.79, up 2.0% YoY).
Data Contradiction: Customer Churn vs Narrative
Management claims that 'repeat order rates among recent customer cohorts are performing at levels consistent with what we saw prior to the ecommerce migration.' However, the data shows DTC Active Customers plunged to 553,000—a drop of 18.5% YoY and roughly 46,000 fewer customers than just last quarter (25Q4). If recent cohorts are strong, historical cohorts are churning at an alarming rate.
Liquidity Constraint on Growth
Total cash, cash equivalents, and restricted cash sit at a perilous $10.4M (down from $11.8M in 25Q4). Operating cash flow remains negative (-$0.7M). Management intends to 'scale spend strategically' to drive sequential revenue growth, but with barely $10M in the bank, they lack the war chest to aggressively buy market share if customer acquisition costs spike.
Macro Pressures: Tariffs and Inflation
While Grove is rebuilding internally, external macro forces remain a headwind. Management continues to flag tariffs, inflation, and interest rates as ongoing risks. Given Grove's reliance on third-party wellness and personal care brands to drive basket sizes, any tariff-driven cost increases could threaten their recently improved 54.8% gross margin.
Extreme Ingredient Curation as a Moat
Grove expanded its banned or restricted ingredient list to over 10,000 items in Q1, including over 3,000 outright bans. This positions the company not just as a retailer, but as an aggressive gatekeeper for human health, differentiating them from mass-market retailers like Amazon or Target.
Other KPIs
Decelerating. This figure represents an 18.5% YoY decline and is down substantially from the 807,000 active customers reported two years prior. The recurring nature of Grove's model means this shrinking base mathematically caps near-term revenue generation until new acquisition outpaces churn.
Accelerating improvement. Measured as pounds of plastic per $100 in net revenue, this metric improved from 0.99 pounds in 25Q1 to 0.84 pounds in 26Q1. This validates the company's core ESG mission and appeals to their highly conscious target demographic.
Guidance
Raised from prior guidance of $140M-$150M. While management expects sequential quarterly growth from the 26Q1 trough, the midpoint of this guidance ($147.5M) still implies a decelerating YoY trend, representing an approximate 15% full-year decline from FY25's $173.7M.
Reversing. Raised from prior guidance of 'approximately breakeven.' This confirms that the Q4 and Q1 positive EBITDA results are not anomalies, but the new structural baseline for the company.
Key Questions
Customer Acquisition Costs (CAC)
You noted that CAC justifies a gradual increase in investment. What specific CAC-to-LTV ratio are you seeing with the new app, and how much cash are you willing to burn from your $10.4M balance to fund this marketing re-acceleration?
Cohort Churn Dynamics
If recent customer cohorts are performing at pre-migration levels, what is driving the severe 46,000 sequential drop in active customers from Q4? Are legacy cohorts churning faster than modeled?
M&A and Strategic Alternatives
In prior quarters, management explicitly noted evaluating strategic options including divestitures or partnerships. Does the raised FY26 guidance mean you are committed to the standalone path, or are strategic alternatives still actively on the table?